Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan

BACKGROUND: The use of inhaled corticosteroid (ICS) in patients with chronic obstructive pulmonary disease (COPD) decreases the frequency of COPD exacerbations. Recently, pneumonia was reported as a complication of ICS in patients with COPD. However, there have been few reports concerning the relati...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirano, Ryosuke, Fujita, Masaki, Matsumoto, Takemasa, On, Rintaro, Watanabe, Kentaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207395/
https://www.ncbi.nlm.nih.gov/pubmed/30498340
http://dx.doi.org/10.2147/COPD.S180349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207395/
https://www.ncbi.nlm.nih.gov/pubmed/30498340
http://dx.doi.org/10.2147/COPD.S180349

Ejemplares similares